POMS MES Goes Live at Mallinckrodt

22 October 1998

POMS MES Goes Live at Mallinckrodt

    HERNDON, Va. and ST. LOUIS, Mo.--(BW HealthWire)--Oct. 22, 1998--POMS Corp. and Mallinckrodt Inc. announced Thursday that POMS MES has been successfully implemented at one of Mallinckrodt's manufacturing facilities located in St. Louis, Mo.
    POMS MES is being used as a complete electronic batch record system for the entire manufacturing process, from work order generation through electronic review of completed batch records. Jim Freeman, of the St. Louis site, stated:

    "We have already seen significant benefits from our POMS MES implementation, including a 50% reduction in product review and approval time, and a 60% reduction in batch record errors.
    "We selected POMS MES after a comprehensive evaluation of all MES vendors that serve the healthcare products industries, including thorough product evaluations and reference site visits. We concluded that POMS MES is a functionally superior, more complete solution with a proven track record of compliance with FDA requirements.
    "Moreover, we are convinced that we will enjoy a long and successful relationship with POMS Corporation."

    Christopher Fountain, Executive Vice President of Sales and Marketing of POMS Corp., added:

    "Mallinckrodt is a leader in primary chemicals manufacturing. We are extremely pleased with the quantitative results Mallinckrodt has achieved though using POMS MES. These results make clear the financial benefits associated with using our products."

    POMS Corp. is committed to improving the effectiveness and competitiveness of regulated manufacturers by delivering proven, world-class MES solutions that integrate seamlessly into the manufacturing supply chain.
    POMS is the most widely used MES solution in the healthcare products industries (pharmaceutical, biopharmaceutical, medical devices), with more than 8,000 users across 15 countries and 39 validated sites worldwide.
    POMS Corp. customers include Baxter Healthcare, Boehringer Ingelheim, Hoechst Marion Roussel, Novartis Pharmaceuticals, and RP Scherer. Information about POMS Corp.'s products and services is available at www.poms.com.
    Based in St. Louis, Mallinckrodt Inc. has three healthcare product operating groups: Imaging, Pharmaceuticals and Respiratory. The company operates in more than 100 countries globally and had fiscal 1998 net sales of $2.4 billion. The Mallinckrodt web site address is www.mallinckrodt.com.

    (C) 1998 POMS Corp. All rights reserved. POMS is a registered trademark and POMS is a trademark of POMS Corp.